The wound healing cascade and GHK-Cu: Normal wound healing occurs in four overlapping phases: Hemostasis clotting Inflammation immune cell recruitment Proliferation new tissue formation Remodeling scar maturation GHK-Cu appears to favorably influence phases 2, 3, and 4 simultaneously: In the inflammatory phase , it reduces pro-inflammatory cytokines (IL-6, TNF-) while preserving necessary immune signaling In the proliferative phase , it stimulates keratinocyte migration and fibroblast proliferation, accelerating epithelial coverage In the remodeling phase , it promotes type I collagen deposition over type III (scar) collagen, leading to better scar outcomes This multi-phase tissue repair activity makes GHK-Cu a compound of interest when studied alongside other regenerative peptides
Variable GPX4 and TfR1 expression levels in papillary thyroid cancer cell lines To examine the relative expression of GPX4 in thyroid cancer cell lines, we performed RT-qPCR on K1, MDA-T32, MDA-T68, and TPC-1 cells, and control human thyroid fibroblasts (HThF)
Typical research dosing window: 200-500 mcg of the combined blend per dosing event (giving 100-250 mcg of each peptide), 1-2 times per 24h cycle in rodent recovery models
Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia
